Mersana Therapeutics Provides Business Update and Announces Fourth Quarter and Full Year 2023 Financial Results

Go back to Mersana Therapeutics Provides Business Update and Announces Fourth Quarter and Full Year 2023 Financial Results
(NASDAQ: MRSN) Delayed: 29.08 --0 (-0%)
Previous Close $29.08    52 Week High $ 
Open $29.08    52 Week Low $ 
Day High $29.08    P/E N/A 
Day Low $29.08    EPS $ 
Volume 1,082,895